ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

0LC7 Syros Pharmaceuticals Inc

11.96
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 317k1.1M2.05M1.98M15.09M23.49M14.88M9.94M
Operating Income -47.96M-54.69M-64.3M-77.74M-82.3M-99.42M-135.87M-128.99M
Pre Tax Income -47.74M-54.01M-62.28M-75.44M-84.04M-86.56M-94.65M-164.57M
Net Income -51.42M-54.01M-62.28M-75.44M-84.04M-86.56M-94.65M-164.57M
Preferred Dividends -3.68M0000000
Basic Earnings Per Share (EPS) -2.199-2.044-1.844-1.739-1.495-1.396-4.671-7.812
EBIT -47.74M-54.01M-62.28M-75.44M-82.3M-99.42M-135.87M-128.99M
EBITDA -46.69M-53.16M-62.69M-75.22M-79.52M-96.66M-133.17M-126.69M

Your Recent History

Delayed Upgrade Clock